CXCL1 expression may be upregulated in prostate tumors [154], but other available studies show either no difference in the expression of this chemokine in prostate cancer [155] or in serum levels in prostate cancer patients relative to healthy subjects [156]. This evidence concerns the gene CXCL1 and prostate cancer.